申请人:ZENECA LIMITED
公开号:EP0739891A2
公开(公告)日:1996-10-30
Compounds of formula I
wherein Q1, Q2, Q3, Q4 and Q5 have any of the meanings given in the specification, their N-oxides, and their pharmacuetically acceptable salts are nonpeptide antagonists NKA, useful for the treatment of asthma, etc. Also disclosed are pharmaceutical compositions, processes for preparing the compounds of formula I and intermediates.
式 I 的化合物
其中 Q1、Q2、Q3、Q4 和 Q5 具有说明书中给出的任何含义,它们的 N-氧化物和它们的药学上可接受的盐是非肽拮抗剂 NKA,可用于治疗哮喘等。还公开了药物组合物、制备式 I 化合物的工艺和中间体。